Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
about
Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Molecular biological design of novel antineoplastic therapies.Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.
P2860
Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@ast
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@en
type
label
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@ast
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@en
prefLabel
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@ast
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@en
P2093
P356
P1476
Genetically engineered monoclo ...... ry of chemotherapeutic agents.
@en
P2093
P304
P356
10.2174/1381612003401109
P577
2000-02-01T00:00:00Z